Institutional investors hold a majority ownership of ISIS through the 90.98% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended December 2013, these large investors purchased a net $553.0 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SECTORAL ASSET MANAGEMENT, INC. Bought 781.0 Thousand shares of Isis Pharmaceuticals Inc
APEX CAPITAL MANAGEMENT, INC. Bought 757.9 Thousand shares of Isis Pharmaceuticals Inc